(Q37593243)

21 August 2017

title

Smoking cessation: How compelling is the evidence? A review (English)

1 reference

21 August 2017

Philip Tønnesen

1

1 reference

21 August 2017

publication date

1 July 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

91 Suppl 1

1 reference

21 August 2017

page(s)

S15-25

1 reference

Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

The genetic determinants of smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Smoking cessation guidelines for health professionals: an update. Health Education Authority

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

The effectiveness of personally tailored computer-generated advice letters for smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

A controlled trial of an expert system and self-help manual intervention based on the stages of change versus standard self-help materials in smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Telephone counseling for smoking cessation: rationales and meta-analytic review of evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

The effectiveness of callback counselling for smoking cessation: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Telephone counselling for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Physician advice for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Nursing interventions for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Group behaviour therapy programmes for smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Real-world efficacy of prescription and over-the-counter nicotine replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Nicotine receptor partial agonists for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

A meta-analysis of acupuncture techniques for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Laser acupuncture for adolescent smokers--a randomized double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

The mortality of doctors in relation to their smoking habits: a preliminary report. 1954

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Costs of employee smoking in the workplace in Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Economic appraisal of asthma and COPD care: a literature review 1980-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Smoking and lung function of Lung Health Study participants after 11 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Preclinical development of a vaccine 'against smoking'.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

CB1 receptor antagonists for the treatment of nicotine addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

The Influence of Smoking Cessation on the Prevalence of Overweight in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

Keeping science on top in drug evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2809%2970004-1

7 January 2021

10.1016/S0168-8510(09)70004-1

Identifiers

DOI

1 reference

21 August 2017

1 reference